CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
The most recent articles from:
CMAJ
-
Observational Study
Observed versus expected rates of myocarditis after SARS-CoV-2 vaccination: a population-based cohort study.
Postmarketing evaluations have linked myocarditis to SARS-CoV-2 mRNA vaccines. We sought to estimate the incidence of myocarditis after mRNA vaccination against SARS-CoV-2, and to compare the incidence with expected rates based on historical background rates in British Columbia. ⋯ Although absolute rates of myocarditis were low, vaccine type, age and sex are important factors to consider when strategizing vaccine administration to reduce the risk of postvaccination myocarditis. Our findings support the preferential use of the BNT162b2 vaccine over the mRNA-1273 vaccine for people aged 18-29 years.